Owkin
Owkin is an AI biotech company that uses artificial intelligence to identify new treatments, optimize clinical trials and develop AI diagnostics.
Content by Owkin
|2 min read
First Patient Dosed in Phase 1 Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors
OKN4395 is the first compound to be developed using K1.0, Owkin’s AI-powered operating systemPage 1 of 1
